myirislogo
14 October, 2019 10:54 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Tata Motors 128.30 5.73
Tata Stl 351.10 3.45
State Bank O 257.60 1.22
Ong Corp 132.05 2.29
Icici Bank 430.55 0.50
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Dishman Pharmaceuticals & Chemicals Limited
Dishman Pharmaceuticals & Chemicals Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:32526NSE:DISHMANBloomberg:DISH@INReuters:DISH.BO
Market Lot: 1Face Value: 2ISIN Demat: INE353G01020
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
02-FEB-17 Dishman Pharmaceuticals & Chemicals, a manufacturer of active ingredients, announced that the company's Bavla facility was successfully inspected by the US FDA in July, 2016, which was intimated to the stock exchanges on July 09, 2016. 14-JUL-16 Dishman Pharmaceuticals & Chemicals, a manufacturer of active ingredients, wholly owned subsidiary, namely Carbogen Amcis AG., Switzerland, had successfully completed US FDA inspection for i...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Dishman Pharmaceuticals gets EIR for Bavla facility  -IRIS 02-Feb-17
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Mar-2016(12)31-Mar-2015 (12)31-Mar-2014 (12)
Net sales 4928.074786.934719.93
Other Income621.82669.98559.76
Total Income5549.895456.915279.69
Cost of goods sold3469.284178.642970.70
OPBDIT2080.611278.272308.99
PAT871.53584.78867.87
Gross Block---
Equity capital161.40161.39161.39
EPS (Rs.)-7.2510.75
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-11.26 - 27.173.45 - 10.27
Debt / Equity (x)---
Operating margin (% of OI)37.523.443.7
Net margin (% of OI)15.710.716.4
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Bhadr Raj Chambers
Swastik Cross Road
Navrangpura
Ahmedabad
Gujarat-380 009
PHONE
(079) 2644 3053/ 5807
FAX
(079) 2642 0198
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer